Traumatic Injury Clinical Trial
Official title:
Use of 81 vs 325mg of ASA in Treatment of BCVI: A Feasibility RCT
Blunt cerebrovascular injury (BCVI), or injury to the carotid and vertebral arteries, occurs in 1-3% of blunt traumas, often as a result of injury to the head, neck, or chest. If unrecognized or untreated, BCVI can lead to stroke, which occurs in approximately 20% of untreated patients, potentially causing significant and sometimes permanent disability. Early diagnosis and treatment significantly reduce the risk of stroke. Currently, there is wide variation across centers and trauma care providers in treatment strategies for BCVI and the most recent guidelines are unable to make specific recommendations about the optimal agent and/or dose of treatment to reduce the risk of stroke after BCVI while minimizing bleeding complications in patients with multiple traumatic injuries. Recent systematic reviews and meta-analyses evaluating the most common treatment strategies for BCVI have shown similar stroke rates with the use of anticoagulants (usually heparin) vs. antiplatelets (usually aspirin/ASA), however, treatment with antiplatelets was associated with a lower risk of bleeding complications. The optimal dose of ASA for stroke prevention while minimizing bleeding complications is unknown, and more research is required to inform future care. This project will investigate two doses of antiplatelet therapy (81 mg daily vs. 325 mg daily aspirin) for BCVI treatment, and will look at the risk of stroke and bleeding complications with each strategy. The goal of the research is to determine whether a large-scale study looking at this question is feasible, which will ultimately help determine the best medical therapy for patients with BCVI.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04992130 -
Sport Concussion Performance-Based Prevention Program
|
N/A | |
Recruiting |
NCT05451394 -
Prevention of Injury in Military Settings Through the Use of Body Awareness.
|
N/A | |
Withdrawn |
NCT03928015 -
Evaluation of Dronabinol For Acute Pain Following Traumatic Injury
|
Phase 2 | |
Recruiting |
NCT04588311 -
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
|
Phase 3 | |
Recruiting |
NCT05437575 -
Prehospital Analgesia INtervention Trial (PAIN)
|
Phase 3 | |
Recruiting |
NCT06034834 -
Near-Infrared Imaging for Perfusion Assessment of Traumatic Soft Tissue and Skeletal Injuries
|
N/A | |
Recruiting |
NCT05568888 -
Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )
|
Phase 3 | |
Completed |
NCT02412982 -
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients
|
Phase 4 | |
Withdrawn |
NCT01497678 -
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center
|
N/A | |
Completed |
NCT05225441 -
National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
|
||
Completed |
NCT03927729 -
Use of Methoxyflurane (Penthrox) as an Antalgic in Hospital Trauma
|
N/A | |
Not yet recruiting |
NCT06366282 -
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
|
N/A | |
Completed |
NCT04778332 -
Trottinettes Urgences 2019-2020
|
||
Recruiting |
NCT06404177 -
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
|
Phase 3 | |
Recruiting |
NCT05086757 -
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
|
N/A | |
Completed |
NCT03628846 -
Opioid Use After Traumatic Injury in Adolescents
|
||
Active, not recruiting |
NCT05320445 -
A Psychosocial Transitional Group to Improve Adaptation, Coping and Mental Health Outcomes Following Trauma
|
N/A | |
Completed |
NCT01771055 -
Direct Peritoneal Resuscitation Effects in the Damage Control Patient
|
N/A | |
Completed |
NCT01485419 -
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
|
N/A | |
Completed |
NCT04980937 -
Peroneal Nerve Injury: a 20- Year Retrospective Case Series Study
|